Efficacy and safety of eribulin as first- to third-line treatment in patients with advanced or metastatic breast cancer previously treated with anthracyclines and taxanes von Maeda, Shigeto, Saimura, Michiyo, Minami, Shigeki, Kurashita, Kaname, Nishimura, Reiki, Kai, Yuichiro, Yano, Hiroshi, Mashino, Kohjiro, Mitsuyama, Shoshu, Shimokawa, Mototsugu, Tamura, Kazuo

Volltext

Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study von Tanaka, Maki, Takamatsu, Yasushi, Anan, Keisei, Ohno, Shinji, Nishimura, Reiki, Yamamoto, Yutaka, Masuda, Norikazu, Mitsuyama, Shoshu, Tamura, Kazuo

Volltext

P303 Efficacy and safety of neoadjuvant weekly paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide: A multicenter study von Anan, K, Tanaka, M, Yoshinaga, Y, Maeda, S, Yasuda, Y, Hayashi, M, Yamanaka, T, Toyoshima, S, Tamura, K, Mitsuyama, S

Volltext

Longitudinal efficacy and safety of capecitabine and cyclophosphamide as early-line treatment in patients with metastatic breast cancer: A prospective cohort study by the Kyushu Br... von Mashino, Kohjiro, Tanaka, Maki, Yamaguchi, Miki, Nishimura, Reiki, Yamamoto, Yutaka, Ueo, Hiroaki, Tanaka, Toshihiro, Koga, Kenichiro, Yoshiyama, Tomoyuki, Mitsuyama, Shoshu, Tamura, Kazuo, Kyushu Breast Cancer Study Group

Volltext

Dosage of Capecitabine and Cyclophosphamide Combination Therapy in Patients with Metastatic Breast Cancer von OHNO, Shinji, MITSUYAMA, Shoshu, TAMURA, Kazuo, NISHIMURA, Reiki, TANAKA, Maki, HAMADA, Yuzo, KUROKI, Shoji

Volltext

Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study von Nishimura, Reiki, Ogawa, Takahiro, Kato, Masato, Tanaka, Maki, Hamada, Yuzo, Shibata, Takao, Ishikawa, Emi, Koga, Toshihiro, Mitsuyama, Shoshu, Tamura, Kazuo

Volltext